Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease

Author： Dransfield Mark T   Bailey William C  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.8, 2004-08, pp. : 1815-1826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Salmeterol/Fluticasone Propionate: A Review of its Use in the Treatment of Chronic Obstructive Pulmonary Disease

By Keating Gillian M.   McCormack Paul L.  

Drugs, Vol. 67, Iss. 16, 2007-01 ,pp. : 2383-2405

Adis International

Access to resources Recommend Favorite

Evaluation of salmeterol xinafoate plus fluticasone propionate for the treatment of chronic obstructive pulmonary disease

By Restrepo Ruben D   Tate Andrew   Coquat Joshua  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 14, 2013-10 ,pp. : 1993-2002

Informa Healthcare

Access to resources Recommend Favorite

Inhaled Salmeterol/Fluticasone Propionate: A Review of its Use in Chronic Obstructive Pulmonary Disease

By Fenton Caroline   Keating Gillian M.  

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1975-1996

Adis International

Access to resources Recommend Favorite

Salmeterol/Fluticasone Propionate Combination

By Spencer C.M.   Jarvis B.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 933-940

Adis International

Access to resources Recommend Favorite

Inhaled Salmeterol: A Review of its Efficacy in Chronic Obstructive Pulmonary Disease

By Jarvis B.   Markham A.  

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 441-472

Adis International

Access to resources Recommend Favorite